Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cell Source, Inc. (CLCS)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 24,429,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. Co.'s main prospective product is its patented Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Co.'s target indications include: lymphoma, leukemia and multiple myeloma through the facilitation of stem cell transplantation acceptance, treatment of end stage kidney disease and other non-malignant organ diseases through improved organ transplantation, and treating a variety of cancers and non-malignant diseases.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 27
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Friedman Benzion Abraham Director   –       •       •   2021-06-30 4 A $0.75 $14,580 I/I 19,440 4,408,184     -
   Zolty David Director   –       •      –    2021-06-30 4 A $0.75 $3,645 I/I 4,860 1,127,504     -
   Soave Darlene Director   –       •       •   2021-06-30 4 A $0.75 $44,630 D/D 59,507 174,434     -
   Brown Dennis M Director   –       •      –    2021-06-30 4 A $0.75 $2,232 D/D 2,976 114,927     -
   Soave Darlene   –       •      –    2021-03-25 3 IO $0.00 $0 D/D 0 258,414     -
   Brown Dennis M Director   –       •      –    2020-12-29 4 A $0.75 $2,269 D/D 3,025 111,951     -
   Zolty David Director   –       •      –    2020-12-29 4 A $0.75 $3,706 I/I 4,941 1,117,784     -
   Friedman Benzion Abraham Director   –       •       •   2020-12-29 4 A $0.75 $14,754 I/I 19,672 4,471,200     -
   Brown Dennis M Director   –       •      –    2020-06-30 4 A $0.75 $2,244 D/D 2,992 108,926     -
   Zolty David Director   –       •      –    2020-06-30 4 A $0.75 $3,665 I/I 4,887 1,112,843     -
   Friedman Benzion Abraham Director   –       •       •   2020-06-30 4 A $0.75 $14,660 I/I 19,547 4,451,438     -
   Brown Dennis M Director   –       •      –    2019-12-31 4 A $0.75 $4,451 D/D 5,934 105,934     -
   Zolty David Director   –       •      –    2019-12-31 4 A $0.75 $4,815 I/I 6,420 1,107,956     -
   Friedman Benzion Abraham Director   –       •       •   2019-12-31 4 A $0.75 $19,256 I/I 25,675 4,431,891     -
   Zolty David Director   –       •      –    2019-06-26 4 A $0.75 $1,004 I/I 1,339 1,101,536     -
   Friedman Benzion Abraham Director   –       •       •   2019-06-26 4 A $0.75 $4,017 I/I 5,356 4,406,216     -
   Zolty David Director   –       •      –    2018-12-31 4 A $0.75 $1,021 I/I 1,361 1,100,197     -
   Friedman Benzion Abraham Director   –       •       •   2018-12-31 4 A $0.75 $4,083 I/I 5,444 4,400,860     -
   Zolty David Director   –       •      –    2018-08-21 4 A $0.75 $1,251 I/I 1,668 1,098,836     -
   Friedman Benzion Abraham Director   –       •       •   2018-08-21 4 A $0.75 $5,004 I/I 6,672 4,395,416     -
   Zolty David Director   –       •      –    2017-12-04 4 A $0.75 $1,013 I/I 1,350 1,097,168     -
   Friedman Benzion Abraham Director   –       •       •   2017-12-04 4 A $0.75 $4,050 I/I 5,400 4,388,744     -
   Friedman Benzion Abraham Director   –       •       •   2015-04-01 3 IO $0.00 $0 I/I 0 4,383,344     -
   Shimrat Itamar CEO and CFOOfficer   •       •      –    2015-04-01 3 IO $0.00 $0 D/D 0 575,004     -
   Zolty David Director   –       •      –    2015-04-01 3 IO $0.00 $0 D/D 0 1,095,818     -

  27 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed